| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cormedix Inc. (CRMD) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. CRMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | $6.83M | - | |
| COO | 278.5K | $2.46M | - | |
| Other | 269.1K | $2.37M | - | |
| Dir | 201.0K | $1.77M | - | |
| Other | 133.2K | $1.17M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2022 | Todisco Joseph76 | Chief Executive Officer | Buy | 4,700 | $3.92 | $18,424.00 | +2.2% | -0.8% | +2.5% | |
| May 17, 2022 | Kaplan Myron | Director | Buy | 5,000 | $3.78 | $18,900.00 | +3.2% | +8.1% | +14.5% | |
| May 16, 2022 | Todisco Joseph76 | Chief Executive Officer | Buy | 10,000 | $3.38 | $33,800.00 | +4.8% | +14.4% | +23.5% | |
| Dec 6, 2021 | David Matthew T | Interim CEO And CFO | Buy | 1,000 | $4.50 | $4,500.00 | +46.5% | -5.8% | -14.5% | |
| Dec 6, 2021 | David Matthew T | Interim CEO And CFO | Buy | 1,000 | $4.50 | $4,500.00 | +46.5% | -5.8% | -14.5% | |
| Nov 17, 2021 | David Matthew T | Interim CEO And CFO | Buy | 1,000 | $5.07 | $5,070.00 | +87.0% | -18.7% | -21.5% | |
| Nov 16, 2021 | Kaplan Myron | Director | Buy | 10,000 | $5.14 | $51,400.00 | +6.1% | -23.7% | -28.8% | |
| May 21, 2021 | Masson-Hurlburt Elizabeth60 | EVP, Head Of Clinical Ops | Sell | 8,000 | $6.92 | $55,393.60 | -100% | -18.7% | -51.1% | |
| May 17, 2021 | Kaplan Myron | Director | Buy | 15,000 | $6.03 | $90,477.00 | +10.0% | -3.7% | -38.6% | |
| Sep 4, 2020 | Lefkowitz Steven W | Director | Buy | 5,715 | $3.99 | $22,815.70 | +5.1% | - | - |